Home > Balance Sheet > NGL FINECHEM

NGL FINECHEM
Total Non-Current Liabilities

    Back to Balance Sheet
NGL FINECHEM is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NGL FINECHEM
Please provide your vote to see the results

NGL FINECHEM Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Total Non-Current Liabilities ₹69 Cr₹41 Cr₹6.32 Cr₹6.24 Cr₹8.06 Cr

What is the latest Total Non-Current Liabilities ratio of NGL FINECHEM ?

The latest Total Non-Current Liabilities ratio of NGL FINECHEM is ₹69 Cr based on Mar2026 Consolidated results.
Year Total Non-Current Liabilities
Mar2026₹69 Cr
Mar2025₹41 Cr
Mar2024₹6.32 Cr
Mar2023₹6.24 Cr
Mar2022₹8.06 Cr

How is Total Non-Current Liabilities of NGL FINECHEM Trending?

Years Total Non-Current Liabilities % Change
Mar2026 ₹69 Cr
67.27
Mar2025 ₹41 Cr
549.52
Mar2024 ₹6.32 Cr
1.27
Mar2023 ₹6.24 Cr
-22.60
Mar2022 ₹8.06 Cr -

Compare Total Non-Current Liabilities of peers of NGL FINECHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NGL FINECHEM ₹1,816.4 Cr -15.3% -6.5% 180.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹451,675.0 Cr -3% -2.6% 21.3% Stock Analytics
DIVIS LABORATORIES ₹225,516.0 Cr -0.5% 17% 43.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹186,190.0 Cr 0.6% 2.7% 35.5% Stock Analytics
CIPLA ₹115,523.0 Cr -2.2% 0.8% -2.4% Stock Analytics
DR REDDYS LABORATORIES ₹99,493.4 Cr -1.1% -1.6% -0.8% Stock Analytics


NGL FINECHEM Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NGL FINECHEM

-15.3%

-6.5%

180.8%

SENSEX

-1%

0.7%

-3.6%


You may also like the below Video Courses